US 10556945
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10556945 (Antagonist antibodies directed against calcitonin gene-related peptide and methods using same) held by TEVA PHARMACEUTICALS INTERNATIONAL GMBH expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICALS INTERNATIONAL GMBH
- Grant date
- Tue Feb 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K2039/55